Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To assess the safety and effectiveness of two doses of SugarDown in two different doses vs.
placebo on serum glucose levels after meals in subjects with Type 2 Diabetes treated with
metformin alone. There will be five visits, a screening visit, baseline visit, and 3
treatment visits. The study duration will be five weeks. Subjects will all receive placebo
tablets at the baseline visit, eat a standard rice meal, and then serum glucose levels will
be measured in frequent intervals over four hours immediately following the meal. Subjects
will be randomized to one of the six treatment sequences. Patients will take in an unknown
order one week of placebo, one week of 4 g dose and one week of 8 g dose of SugarDown
immediately before breakfast, lunch and dinner meals. Patients will continue their usual
metformin regimen during the trial period.